Wuxi, China, Oct. 24, 2025 — Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH; the “Company” or “PHH”) announced a modification to its ticker symbol. Effective Tuesday, October 28, 2025, the Company’s ordinary shares will commence trading on Nasdaq under the new symbol “BYAH,” replacing its current “PHH” designation.
“To prevent potential confusion with a delisted company that utilized the same symbol, we will officially change the ticker symbol,” commented Xiaoqiu Zhang, the Company’s CEO. “The transition of the Company’s ticker symbol to ‘BYAH’ is anticipated to positively contribute to building the Company’s long-term brand influence and enhancing our brand value.”
Existing shareholders are not required to take any action regarding this ticker symbol change. The Company’s ordinary shares will continue to be listed on Nasdaq, and the CUSIP will remain unchanged.
Forward-Looking Statements
All statements in this announcement, other than those of historical fact, are considered forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties, and are based on current expectations and projections concerning future events and financial trends that the Company believes may impact its financial condition, operational results, business strategy, and financial projections. Investors can identify these forward-looking statements through words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent events or circumstances, or changes in its expectations, except as may be legally required. While the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will prove correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC.
About Park Ha Biological Technology Co., Ltd.
Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in the development of its private skincare label, direct sales of skincare products, and the promotion of franchise alliances under its proprietary brand “Park Ha.” The Company is dedicated to offering cost-effective solutions for skin problems and enhancing the confidence of women seeking skin treatment. As of April 30, 2025, the Company operates three directly owned stores and 39 franchisees across China; 38 of these operate under the “Park Ha” store name, and one under “Geni.” As part of its value-added service for products, the Company provides a “light beauty experience,” which is a quick, complimentary after-sales beauty service performed at its directly-operated and franchise stores. For additional information, please visit the Company’s website: .
Forward-Looking Statements
Certain statements within this announcement constitute forward-looking statements. These forward-looking statements incorporate known and unknown risks and uncertainties, and are grounded in the Company’s current expectations and projections regarding future events that the Company believes may influence its financial condition, operating results, business strategy, and financial needs. Investors may identify many (but not all) of these statements through the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may,” or other similar expressions in this prospectus. The Company disclaims any obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances, or alterations in its expectations, except as may be mandated by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot guarantee their accuracy, and the Company cautions investors that actual results may materially diverge from anticipated results and encourages investors to review other factors that could affect its future results in the Company’s registration statement and other filings with the SEC.
For more information, please contact:
Olivia Li
Email: ir_parkha@163.com
